SCHEMBL15329374

SCHEMBL15329374

N#Cc1nn(-c2c(F)cc(C(F)(F)F)cc2Cl)c(N)c1[S+]([O-])C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 20/20 0.53
GABRD O14764 20/20 0.53
GABRA1 P14867 20/20 0.53
GABRB1 P18505 20/20 0.53
GABRG2 P18507 20/20 0.53
GABRB3 P28472 20/20 0.53
GABRA5 P31644 20/20 0.53
GABRA3 P34903 20/20 0.53
GABRA2 P47869 20/20 0.53
GABRB2 P47870 20/20 0.53
GABRA4 P48169 20/20 0.53
GABRE P78334 20/20 0.53
GABRA6 Q16445 20/20 0.53
GABRG1 Q8N1C3 20/20 0.53
GABRG3 Q99928 20/20 0.53
GABRQ Q9UN88 20/20 0.53
NR1I2 O75469 1/20 0.53
LMNA P02545 1/20 0.53
CYP3A4 P08684 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fipronil SCHEMBL15088 0.93 GABRP (0.59) GABRPGABRDGABRA1GABRB1GABRG2
Fipronil SCHEMBL29397350 0.93 GABRP (0.59) GABRPGABRDGABRA1GABRB1GABRG2
Fipronil SCHEMBL2469515 0.93 GABRP (0.59) GABRPGABRDGABRA1GABRB1GABRG2
Fipronil SCHEMBL44222 0.93 GABRP (0.59) GABRPGABRDGABRA1GABRB1GABRG2
Fipronil SCHEMBL7171206 0.93 GABRP (0.59) GABRPGABRDGABRA1GABRB1GABRG2
Fipronil SCHEMBL3351877 0.92 GABRP (0.58) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL14094912 0.89 GABRP (0.53) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL2835863 0.87 GABRB3 (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL15329430 0.87 GABRB3 (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8790587 0.87 GABRP (0.59) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104334534-B Improved process for preparing 1-aryl-5-alkylpyrazole compounds 勃林格殷格翰动物保健美国公司 2020-01-10 CN disclosed
EP-3184510-B1 IMPROVED PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS MERIAL INC (US) 2019-06-12 EP disclosed
EP-3184510-B1 IMPROVED PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS MERIAL INC (US) 2019-06-12 EP disclosed
EP-3184510-A1 IMPROVED PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS Merial, Inc. (US) 2017-06-28 EP disclosed
EP-3184510-A1 IMPROVED PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS Merial, Inc. (US) 2017-06-28 EP disclosed
EP-2852577-B1 IMPROVED PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS MERIAL INC (US) 2017-03-01 EP disclosed
EP-2852577-B1 IMPROVED PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS MERIAL INC (US) 2017-03-01 EP disclosed
US-9273007-B2 Processes for the preparation of 1-aryl-5-alkyl pyrazole compounds MERIAL, INC. (US) 2016-03-01 US disclosed
US-9273007-B2 Processes for the preparation of 1-aryl-5-alkyl pyrazole compounds MERIAL, INC. (US) 2016-03-01 US disclosed
US-9273007-B2 Processes for the preparation of 1-aryl-5-alkyl pyrazole compounds MERIAL, INC. (US) 2016-03-01 US disclosed
US-20150073153-A1 PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS MERIAL LIMITED (US) 2015-03-12 US disclosed
US-20150073153-A1 PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS MERIAL LIMITED (US) 2015-03-12 US disclosed
US-20150073153-A1 PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS MERIAL LIMITED (US) 2015-03-12 US disclosed
US-8937185-B2 Processes for the preparation of 1-aryl-5-alkyl pyrazole compounds MERIAL LIMITED (US) 2015-01-20 US disclosed
US-8937185-B2 Processes for the preparation of 1-aryl-5-alkyl pyrazole compounds MERIAL LIMITED (US) 2015-01-20 US disclosed
US-8937185-B2 Processes for the preparation of 1-aryl-5-alkyl pyrazole compounds MERIAL LIMITED (US) 2015-01-20 US disclosed
US-20130281710-A1 PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS MERIAL LIMITED (US) 2013-10-24 US disclosed
US-20130281710-A1 PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS MERIAL LIMITED (US) 2013-10-24 US disclosed
US-20130281710-A1 PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS MERIAL LIMITED (US) 2013-10-24 US disclosed
WO-2013159094-A2 IMPROVED PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS MERIAL LIMITED (US) 2013-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150073153-A1 PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS SULT1A1, CYP1B1, CYP2F1 GABRP 1164/4885GABRD 2354/4885GABRA1 729/4885
US-20130281710-A1 PROCESSES FOR THE PREPARATION OF 1-ARYL-5-ALKYL PYRAZOLE COMPOUNDS SULT1A1, CYP1B1, CYP2F1 GABRP 1164/4885GABRD 2354/4885GABRA1 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.